HYGEIA HC HLDGS DL-00001 (50I) - Net Assets
Based on the latest financial reports, HYGEIA HC HLDGS DL-00001 (50I) has net assets worth €6.78 Billion EUR (≈ $7.93 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€10.66 Billion ≈ $12.47 Billion USD) and total liabilities (€3.88 Billion ≈ $4.54 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore 50I cash flow metrics to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €6.78 Billion |
| % of Total Assets | 63.62% |
| Annual Growth Rate | 10.95% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 9.35 |
HYGEIA HC HLDGS DL-00001 - Net Assets Trend (2021–2025)
This chart illustrates how HYGEIA HC HLDGS DL-00001's net assets have evolved over time, based on quarterly financial data. Also explore how large is HYGEIA HC HLDGS DL-00001's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for HYGEIA HC HLDGS DL-00001 (2021–2025)
The table below shows the annual net assets of HYGEIA HC HLDGS DL-00001 from 2021 to 2025. For live valuation and market cap data, see HYGEIA HC HLDGS DL-00001 stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €6.78 Billion ≈ $7.93 Billion |
+1.65% |
| 2024-12-31 | €6.67 Billion ≈ $7.80 Billion |
+6.71% |
| 2023-12-31 | €6.25 Billion ≈ $7.31 Billion |
+26.62% |
| 2022-12-31 | €4.94 Billion ≈ $5.78 Billion |
+10.33% |
| 2021-12-31 | €4.48 Billion ≈ $5.23 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to HYGEIA HC HLDGS DL-00001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 582.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €2.07 Billion | 30.59% |
| Other Components | €4.70 Billion | 69.41% |
| Total Equity | €6.77 Billion | 100.00% |
HYGEIA HC HLDGS DL-00001 Competitors by Market Cap
The table below lists competitors of HYGEIA HC HLDGS DL-00001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Polarean Imaging Plc
LSE:POLX
|
$11.75K |
|
Distil Plc
LSE:DIS
|
$11.75K |
|
Hana Microelectronics Public Company Limited
F:HAA1
|
$11.77K |
|
Becket Invest Plc
LSE:TAB
|
$11.97K |
|
Sabien Technology Group Plc
LSE:SNT
|
$11.41K |
|
Mingzhu Logistics Holdings Ltd
NASDAQ:YGMZ
|
$11.06K |
|
PipeHawk plc
LSE:PIP
|
$11.05K |
|
PTT Public Company Limited
F:PTOG
|
$10.89K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HYGEIA HC HLDGS DL-00001's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,652,644,000 to 6,768,189,000, a change of 115,545,000 (1.7%).
- Net income of 164,526,000 contributed positively to equity growth.
- Share repurchases of 39,938,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €164.53 Million | +2.43% |
| Share Repurchases | €39.94 Million | -0.59% |
| Other Changes | €-9.04 Million | -0.13% |
| Total Change | €- | 1.74% |
Book Value vs Market Value Analysis
This analysis compares HYGEIA HC HLDGS DL-00001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.10x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €7.21 | €1.06 | x |
| 2022-12-31 | €8.00 | €1.06 | x |
| 2023-12-31 | €9.87 | €1.06 | x |
| 2024-12-31 | €10.72 | €1.06 | x |
| 2025-12-31 | €10.97 | €1.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently HYGEIA HC HLDGS DL-00001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.43%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.10%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 1.58x
- Recent ROE (2.43%) is below the historical average (8.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 9.91% | 19.07% | 0.35x | 1.50x | €-4.19 Million |
| 2022 | 9.66% | 14.92% | 0.44x | 1.47x | €-16.59 Million |
| 2023 | 10.96% | 16.75% | 0.38x | 1.72x | €59.61 Million |
| 2024 | 8.99% | 13.46% | 0.41x | 1.64x | €-67.00 Million |
| 2025 | 2.43% | 4.10% | 0.38x | 1.58x | €-512.29 Million |
Industry Comparison
This section compares HYGEIA HC HLDGS DL-00001's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $5,163,091,908
- Average return on equity (ROE) among peers: -20.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HYGEIA HC HLDGS DL-00001 (50I) | €6.78 Billion | 9.91% | 0.57x | $11.46K |
| China Resources Medical Holdings Company Limited (1PH) | $6.85 Billion | 6.10% | 0.53x | $405.05 Million |
| AEST.MED.INT.HLD.SP.ADR/3 (3FMA) | $9.35 Million | -213.41% | 51.02x | $3.30 Million |
| JINXIN FERT.GRP HD-00001 (3NX) | $8.74 Billion | 1.39% | 0.74x | $656.44 Million |
| REVITALIST L.A.W. LTD (4DO) | $-11.05 Million | 0.00% | 0.00x | $744.60K |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.31 Billion | 4.15% | 1.31x | $19.28 Million |
| COMPASS PATHW SP.ADR (5Y6) | $-52.85 Million | 0.00% | 0.00x | $657.30 Million |
| Bumrungrad Hospital Public Company Limited (BZ7A) | $14.79 Billion | 24.52% | 0.44x | $49.07K |
| Eifelhöhen-Klinik AG (EIF) | $14.69 Million | -6.59% | 3.60x | $10.05 Million |
| Fresenius Medical Care AG & Co. KGaA (FME) | $14.83 Billion | 3.37% | 1.29x | $10.01 Billion |
About HYGEIA HC HLDGS DL-00001
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals, which offer a range of oncology healthcare and other healthcare services. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support servi… Read more